TACROLIMUS ANHYDROUS 8-EPIMER
UNII 294O3172M2

Substance Identification & Data

This profile provides standardized clinical and technical data for Tacrolimus Anhydrous 8-epimer, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 294O3172M2.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 129212-35-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

294O3172M2

CAS Registry Number

129212-35-7

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TACROLIMUS ANHYDROUS 8-EPIMER

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C44H69NO12

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

QJJXYPPXXYFBGM-NCGCDJFJSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

13006299

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

[C@]12([C@H](C)C[C@@H]([C@]([C@@H](OC)C[C@@H](C)C/C(=C/[C@H](CC=C)C(=O)C[C@@H]([C@H]([C@@]([H])(/C(/C)=C/[C@@]3(CC[C@H]([C@H](OC)C3)O)[H])OC([C@]4([H])CCCCN4C(=O)C1=O)=O)C)O)/C)([H])O2)OC)O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tacrolimus Anhydrous 8-epimer. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

8-EPITACROLIMUS

8-EPI-TACROLIMUS

TACROLIMUS 8-EPIMER [USP-RS]

TACROLIMUS ANHYDROUS 8-EPIMER

TACROLIMUS MONOHYDRATE IMPURITY D [EP IMPURITY]

Systematic Nomenclature

(3S,4R,5S,8S,9E,12S,14S,15R,16S,18R,19R,26AS)-5,19-DIHYDROXY-3-((1E)-1-((1R,3R,4R)-4-HYDROXY-3-METHOXYCYCLOHEXYL)PROP-1-EN-2-YL)-14,16-DIMETHOXY-4,10,12,18-TETRAMETHYL-8-(PROP-2-EN-1-YL)-3,4,5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26A-OCTADECAHYDRO-7H-15,19-EPOXYPYRIDO(2,1-C)(1,4)OXAAZACYCLOTRICOSINE-1,7,20,21(23H)-TETRONE

SYS

15,19-EPOXY-3H-PYRIDO(2,1-C)(1,4)OXAAZACYCLOTRICOSINE-1,7,20,21(4H,23H)-TETRONE, 5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26A-HEXADECAHYDRO-5,19-DIHYDROXY-3-(2-(4-HYDROXY-3-METHOXYCYCLOHEXYL)-1-METHYLETHENYL)-14,16-DIMETHOXY-4,10,12,18-TETRAMETHYL-8-(2-PROPENYL)-, (3S-(3R*(E(1S*,3S*,4S*)),4S*,5R*,8R*,9E,12R*,14R*,15S*,16R*,18S*,19S*,26AR*))-

SYS

External Clinical & Regulatory Resources

Previous UNII294MW69GE6

Next UNII294SL62B6H